Introduction stable isotope labelling with amino acids in cell culture (SILAC) was used to quantify protein 80 changes in nuclei isolated from primary RPTE cells at 3 days post infection. In this study ~2000 81 proteins were quantified, and the effect of infection on proteins outside the nucleus could not be 82 assessed . Table S1 . Here, the worksheet ''Plots'' is interactive, enabling generation 106 of graphs of protein expression of any of the human and viral proteins quantified.
107
In uninfected cells, RPTE and HU cells exhibit differential expression of proteins, as expected from proteins showed similar changes in both cell types, although cell type-specific effects were also seen 113 ( Figure S2 ). We reasoned that those protein changes which were important for viral replication 114 would be common to different cell types. By combining the two datasets, we found that just 86 115 cellular proteins, less than 1% of all proteins quantified, were upregulated >2-fold in both RPTE and 
Proteins
The lack of change in the host cell proteome at the earliest time point of 24 hpi suggested little or 156 no effect of virus binding and penetration. To investigate this further a second TMT-based whole 157 cell proteomics experiment (Experiment 2) was conducted repeating 24 and 48 hpi timepoints with 158 an additional earlier 12 hpi timepoint, where RPTE cells were infected with UV-inactivated or 159 unmodified BKPyV at MOI 5 (Figures S3, S4 ). Very few changes in protein abundance were 160 observed at 12 or 24 hpi during infection with unmodified BKPyV, while at 48 hpi cellular proteins 161 upregulated were similar to those observed in the first experiment at the same time point ( Figures   162   S3B-D) . UV-inactivated virus induced virtually no changes at any time point, suggesting that virus 163 replication is necessary to cause the observed changes in host protein abundance ( Figure S3B ).
164

Temporal Analysis of BK Polyomavirus Protein Expression
165
Expression of the early BKPyV proteins, LTAg and stAg, was observed from 24 hpi, closely 166 followed by late proteins, agnoprotein, VP1 and VP2. Profiles from HU and RPTE cells (both 167 experiments) corresponded well ( Figures 1E, S3E ). We were unable to assign peptides to VP3 due 168 to its 100% sequence identity with the C terminus of VP2, and the single unique peptide 169 corresponding to the extreme N-terminus of VP3 was not quantified. Likewise, TruncTAg was not 170 identified due to its similarity to full length LTAg: the only difference in protein sequence are the 171 C-terminal 3 amino acids of TruncTAg, which directly follow a cluster of lysine and arginine 172 residues and so would not be expected to be identified by our mass spectrometry analysis.
173
BKPyV does not cause induction of innate immune responses in infected RPTE cells
174
One surprising observation from our QTV analyses was an apparent lack of an innate immune BKPyV has evolved a highly effective immune-evasion activity, which could be due to either viral 
224
(10 4 U/mL) was as a positive control for innate immune response induction.
226
Activation of RNA and DNA sensors invariably leads to IRF3 phosphorylation and translocation
227
into the nucleus, leading to transcription of type I and III interferons. We analysed whether RPTE 3) or mock infected were either fixed at 48 hpi or stimulated with Poly I:C (2 µg/mL) or stimulatory DNA (2 268 µg/mL) and fixed at 6 h after stimulation.
270
To investigate whether the lack of viral sensing is due to evasion of nucleic acid detection or active BKPyV-induced upregulation of p53 and downregulation of MDM2 was also confirmed by 347 immunofluorescence (Figures 6, S6 ). The E3 ubiquitin ligase MDM2 is a negative regulator of both 348 p53 and itself, leading to ubiquitinylation and degradation of p53 and MDM2 (Barak et al. 1993 ).
349
In addition, p53 is a transcription factor for both itself and MDM2 ( 
411
Select images shown, additional images provided in Figure S6 . then subsequently harvested at 48 hpi and analysed by flow cytometry to compare cell cycle profiles.
428
PD0332991 was used to inhibit CDK4 and 6, which are active in G1 phase, Roscovitine was used 429 to inhibit CDK1 and 2, which are active throughout S, G2, and M phase, and RO-3306 was used to 
526
(A) qPCR to determine viral DNA copy numbers per cell. DNA was extracted from each condition, BKPyV 527 genome copy number was determined, normalised to host gene (TNFα) copy number and compared to the 528 uninhibited control, which was arbitrarily set to 1 (n=6).
529
(B) Expression of viral proteins VP1, VP2, VP3, Agno, and LTAg was determined by immunoblot. Tubulin was 530 used as a loading control.
531
(C) Infectious BKPyV produced in each experimental condition was determined by fluorescent focus unit (FFU)
532
assay and normalised to uninhibited control (arbitrarily set to 1) (n=7).
533
Error bars represent standard deviation. *p < 0.05; ***p < 0.001; ****p < 0. to be destroyed by the proteasome, and so protects p53 from degradation but inhibits p53 581 transcriptional activity prevent induction of de novo MDM2 expression ( Figure 9C) . Therefore, the 582 expression of just LTAg results in decreased MDM2 levels but only a modest increase in p53.
583
During active BKPyV infection, p53 expression is induced by some other effect(s) of virus 584 replication, and these additional copies of p53 are also bound and inactivated by LTAg ( Figure 9D) .
The virus induced stimulation of p53 expression is predicted to be via a DNA damage response 586 pathway, which can be mimicked by inducing a G2 arrest through inhibition of CDK1. 
616
Polyomaviruses have a well-established capacity to drive cells into S-phase by overriding the G1/S 617 checkpoint via the activity of LTAg. It is therefore unsurprising that inhibition of CDK4 and 6 has 618 little-to-no effect on the ability of BKPyV to drive cell cycle progression or to replicate. CDK4 and likely due to inhibition of CDK2 activity, or the combination of inhibiting both CDK1 and 2. 2009). Concentration and purity was assessed by FFU assay and coomassie gel stain respectively.
682
The primary antibodies used in this study were PAb597 against SV40 VP1 (kindly provided by W. ethanol), and centrifuged, followed by a final wash in Buffer 2 (25mM Tris pH7 in 70% ethanol).
749
DNA was eluted with nuclease free water by centrifugation at 16,000× g. Primers and probe for
750
BKPyV genome were designed as described in (Evans et al. 2015 
782
Peptide labelling with tandem mass tags
783
In preparation for TMT labelling, desalted peptides were dissolved in 200 mM HEPES pH 8.5.
784
Peptide concentration was measured by microBCA (Pierce), and 25 µg labelled with TMT reagent.
785
TMT reagents (0.8 mg) were dissolved in 43 µl anhydrous acetonitrile and 3 µl added to peptide at 
797
The sample was vacuum-centrifuged to near dryness and subjected to C18 SPE (Sep-Pak, Waters). set to +/-10 ppm for 70 s. MS2 fragmentation was trigged on precursors 5x10 3 counts and above.
840
Data analysis
841
In the following description, we list the first report in the literature for each relevant algorithm. Mass 842 spectra were processed using a Sequest-based software pipeline for quantitative proteomics,
843
"MassPike", through a collaborative arrangement with Professor Steve Gygi's laboratory at Harvard
844
Medical School. MS spectra were converted to mzXML using an extractor built upon Thermo Table S1 ('Data' worksheet).
892
Hierarchical centroid clustering based on uncentered Pearson correlation, and k-means clustering
893
were performed using Cluster 3.0 (Stanford University) and visualised using Java Treeview
894
(http://jtreeview.sourceforge.net) unless otherwise noted. Table S1 . Interactive spreadsheet of all data in the manuscript. The "DATA" worksheet shows 1094 minimally annotated protein data, with only formatting and normalisation modifying the raw data.
1095
The "Plotter" worksheet enables generation of individual protein abundance changes for both viral 1096 and human proteins over time from experiments 1 and 2. The total number of quantified peptides 1097 and proteins from experiments 1 and 2 are shown in separate workbook sheets.
1098 Table S2 . A list of all quantified proteins from experiments 1 and 2 that match the UniProt keywords Table S3 . Proteins modulated during BK infection. All proteins downregulated or upregulated >2-
1102
fold at any time point during the course of infection (compared to the average of the mock samples).
1103
Results from experiments 1 and 2 are presented.
1104 Table S4 . DAVID functional enrichment analysis from proteins upregulated or downregulated >2- proteins downregulated >2-fold in experiment 2.
